Cargando…
OnTrack Chile for people with early psychosis: a study protocol for a Hybrid Type 1 trial
BACKGROUND: Substantial data from high-income countries support early interventions in the form of evidence-based Coordinated Specialty Care (CSC) for people experiencing First Episode Psychosis (FEP) to ameliorate symptoms and minimize disability. Chile is unique among Latin American countries in p...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444092/ https://www.ncbi.nlm.nih.gov/pubmed/36064643 http://dx.doi.org/10.1186/s13063-022-06661-7 |
_version_ | 1784783138906439680 |
---|---|
author | Mascayano, Franco Bello, Iruma Andrews, Howard Arancibia, Diego Arratia, Tamara Burrone, María Soledad Conover, Sarah Fader, Kim Jorquera, Maria Jose Gomez, Mauricio Malverde, Sergio Martínez-Alés, Gonzalo Ramírez, Jorge Reginatto, Gabriel Restrepo-Henao, Alexandra Rosencheck, Robert A. Schilling, Sara Smith, Thomas E. Soto-Brandt, Gonzalo Tapia, Eric Tapia, Tamara Velasco, Paola Wall, Melanie M. Yang, Lawrence H. Cabassa, Leopoldo J. Susser, Ezra Dixon, Lisa Alvarado, Rubén |
author_facet | Mascayano, Franco Bello, Iruma Andrews, Howard Arancibia, Diego Arratia, Tamara Burrone, María Soledad Conover, Sarah Fader, Kim Jorquera, Maria Jose Gomez, Mauricio Malverde, Sergio Martínez-Alés, Gonzalo Ramírez, Jorge Reginatto, Gabriel Restrepo-Henao, Alexandra Rosencheck, Robert A. Schilling, Sara Smith, Thomas E. Soto-Brandt, Gonzalo Tapia, Eric Tapia, Tamara Velasco, Paola Wall, Melanie M. Yang, Lawrence H. Cabassa, Leopoldo J. Susser, Ezra Dixon, Lisa Alvarado, Rubén |
author_sort | Mascayano, Franco |
collection | PubMed |
description | BACKGROUND: Substantial data from high-income countries support early interventions in the form of evidence-based Coordinated Specialty Care (CSC) for people experiencing First Episode Psychosis (FEP) to ameliorate symptoms and minimize disability. Chile is unique among Latin American countries in providing universal access to FEP services through a national FEP policy that mandates the identification of FEP individuals in primary care and guarantees delivery of community-based FEP treatments within a public health care system. Nonetheless, previous research has documented that FEP services currently provided at mental health clinics do not provide evidence-based approaches. This proposal aims to address this shortfall by first adapting OnTrackNY (OTNY), a CSC program currently being implemented across the USA, into OnTrackChile (OTCH), and then examine its effectiveness and implementation in Chile. METHODS: The Dynamic Adaptation Process will be used first to inform the adaptation and implementation of OTCH to the Chilean context. Then, a Hybrid Type 1 trial design will test its effectiveness and cost and evaluate its implementation using a cluster-randomized controlled trial (RCT) (N = 300 from 21 outpatient clinics). The OTCH program will be offered in half of these outpatient clinics to individuals ages 15-35. Usual care services will continue to be offered at the other clinics. Given the current COVID-19 pandemic, most research and intervention procedures will be conducted remotely. The study will engage participants over the course of 2 years, with assessments administered at enrollment, 12 months, and 24 months. Primary outcomes include implementation (fidelity, acceptability, and uptake) and service outcomes (person-centeredness, adherence, and retention). Secondary outcomes comprise participant-level outcomes such as symptoms, functioning, and recovery orientation. Over the course of the study, interviews and focus groups with stakeholders will be conducted to better understand the implementation of OTCH. DISCUSSION: Findings from this study will help determine the feasibility, effectiveness, and cost for delivering CSC services in Chile. Lessons learned about facilitators and barriers related to the implementation of the model could help inform the approach needed for these services to be further expanded throughout Latin America. TRIAL REGISTRATION: www.ClinicalTrials.govNCT04247711. Registered 30 January 2020. TRIAL STATUS: The OTCH trial is currently recruiting participants. Recruitment started on March 1, 2021, and is expected to be completed by December 1, 2022. This is the first version of this protocol (5/12/2021). |
format | Online Article Text |
id | pubmed-9444092 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-94440922022-09-06 OnTrack Chile for people with early psychosis: a study protocol for a Hybrid Type 1 trial Mascayano, Franco Bello, Iruma Andrews, Howard Arancibia, Diego Arratia, Tamara Burrone, María Soledad Conover, Sarah Fader, Kim Jorquera, Maria Jose Gomez, Mauricio Malverde, Sergio Martínez-Alés, Gonzalo Ramírez, Jorge Reginatto, Gabriel Restrepo-Henao, Alexandra Rosencheck, Robert A. Schilling, Sara Smith, Thomas E. Soto-Brandt, Gonzalo Tapia, Eric Tapia, Tamara Velasco, Paola Wall, Melanie M. Yang, Lawrence H. Cabassa, Leopoldo J. Susser, Ezra Dixon, Lisa Alvarado, Rubén Trials Study Protocol BACKGROUND: Substantial data from high-income countries support early interventions in the form of evidence-based Coordinated Specialty Care (CSC) for people experiencing First Episode Psychosis (FEP) to ameliorate symptoms and minimize disability. Chile is unique among Latin American countries in providing universal access to FEP services through a national FEP policy that mandates the identification of FEP individuals in primary care and guarantees delivery of community-based FEP treatments within a public health care system. Nonetheless, previous research has documented that FEP services currently provided at mental health clinics do not provide evidence-based approaches. This proposal aims to address this shortfall by first adapting OnTrackNY (OTNY), a CSC program currently being implemented across the USA, into OnTrackChile (OTCH), and then examine its effectiveness and implementation in Chile. METHODS: The Dynamic Adaptation Process will be used first to inform the adaptation and implementation of OTCH to the Chilean context. Then, a Hybrid Type 1 trial design will test its effectiveness and cost and evaluate its implementation using a cluster-randomized controlled trial (RCT) (N = 300 from 21 outpatient clinics). The OTCH program will be offered in half of these outpatient clinics to individuals ages 15-35. Usual care services will continue to be offered at the other clinics. Given the current COVID-19 pandemic, most research and intervention procedures will be conducted remotely. The study will engage participants over the course of 2 years, with assessments administered at enrollment, 12 months, and 24 months. Primary outcomes include implementation (fidelity, acceptability, and uptake) and service outcomes (person-centeredness, adherence, and retention). Secondary outcomes comprise participant-level outcomes such as symptoms, functioning, and recovery orientation. Over the course of the study, interviews and focus groups with stakeholders will be conducted to better understand the implementation of OTCH. DISCUSSION: Findings from this study will help determine the feasibility, effectiveness, and cost for delivering CSC services in Chile. Lessons learned about facilitators and barriers related to the implementation of the model could help inform the approach needed for these services to be further expanded throughout Latin America. TRIAL REGISTRATION: www.ClinicalTrials.govNCT04247711. Registered 30 January 2020. TRIAL STATUS: The OTCH trial is currently recruiting participants. Recruitment started on March 1, 2021, and is expected to be completed by December 1, 2022. This is the first version of this protocol (5/12/2021). BioMed Central 2022-09-05 /pmc/articles/PMC9444092/ /pubmed/36064643 http://dx.doi.org/10.1186/s13063-022-06661-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Study Protocol Mascayano, Franco Bello, Iruma Andrews, Howard Arancibia, Diego Arratia, Tamara Burrone, María Soledad Conover, Sarah Fader, Kim Jorquera, Maria Jose Gomez, Mauricio Malverde, Sergio Martínez-Alés, Gonzalo Ramírez, Jorge Reginatto, Gabriel Restrepo-Henao, Alexandra Rosencheck, Robert A. Schilling, Sara Smith, Thomas E. Soto-Brandt, Gonzalo Tapia, Eric Tapia, Tamara Velasco, Paola Wall, Melanie M. Yang, Lawrence H. Cabassa, Leopoldo J. Susser, Ezra Dixon, Lisa Alvarado, Rubén OnTrack Chile for people with early psychosis: a study protocol for a Hybrid Type 1 trial |
title | OnTrack Chile for people with early psychosis: a study protocol for a Hybrid Type 1 trial |
title_full | OnTrack Chile for people with early psychosis: a study protocol for a Hybrid Type 1 trial |
title_fullStr | OnTrack Chile for people with early psychosis: a study protocol for a Hybrid Type 1 trial |
title_full_unstemmed | OnTrack Chile for people with early psychosis: a study protocol for a Hybrid Type 1 trial |
title_short | OnTrack Chile for people with early psychosis: a study protocol for a Hybrid Type 1 trial |
title_sort | ontrack chile for people with early psychosis: a study protocol for a hybrid type 1 trial |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444092/ https://www.ncbi.nlm.nih.gov/pubmed/36064643 http://dx.doi.org/10.1186/s13063-022-06661-7 |
work_keys_str_mv | AT mascayanofranco ontrackchileforpeoplewithearlypsychosisastudyprotocolforahybridtype1trial AT belloiruma ontrackchileforpeoplewithearlypsychosisastudyprotocolforahybridtype1trial AT andrewshoward ontrackchileforpeoplewithearlypsychosisastudyprotocolforahybridtype1trial AT arancibiadiego ontrackchileforpeoplewithearlypsychosisastudyprotocolforahybridtype1trial AT arratiatamara ontrackchileforpeoplewithearlypsychosisastudyprotocolforahybridtype1trial AT burronemariasoledad ontrackchileforpeoplewithearlypsychosisastudyprotocolforahybridtype1trial AT conoversarah ontrackchileforpeoplewithearlypsychosisastudyprotocolforahybridtype1trial AT faderkim ontrackchileforpeoplewithearlypsychosisastudyprotocolforahybridtype1trial AT jorqueramariajose ontrackchileforpeoplewithearlypsychosisastudyprotocolforahybridtype1trial AT gomezmauricio ontrackchileforpeoplewithearlypsychosisastudyprotocolforahybridtype1trial AT malverdesergio ontrackchileforpeoplewithearlypsychosisastudyprotocolforahybridtype1trial AT martinezalesgonzalo ontrackchileforpeoplewithearlypsychosisastudyprotocolforahybridtype1trial AT ramirezjorge ontrackchileforpeoplewithearlypsychosisastudyprotocolforahybridtype1trial AT reginattogabriel ontrackchileforpeoplewithearlypsychosisastudyprotocolforahybridtype1trial AT restrepohenaoalexandra ontrackchileforpeoplewithearlypsychosisastudyprotocolforahybridtype1trial AT rosencheckroberta ontrackchileforpeoplewithearlypsychosisastudyprotocolforahybridtype1trial AT schillingsara ontrackchileforpeoplewithearlypsychosisastudyprotocolforahybridtype1trial AT smiththomase ontrackchileforpeoplewithearlypsychosisastudyprotocolforahybridtype1trial AT sotobrandtgonzalo ontrackchileforpeoplewithearlypsychosisastudyprotocolforahybridtype1trial AT tapiaeric ontrackchileforpeoplewithearlypsychosisastudyprotocolforahybridtype1trial AT tapiatamara ontrackchileforpeoplewithearlypsychosisastudyprotocolforahybridtype1trial AT velascopaola ontrackchileforpeoplewithearlypsychosisastudyprotocolforahybridtype1trial AT wallmelaniem ontrackchileforpeoplewithearlypsychosisastudyprotocolforahybridtype1trial AT yanglawrenceh ontrackchileforpeoplewithearlypsychosisastudyprotocolforahybridtype1trial AT cabassaleopoldoj ontrackchileforpeoplewithearlypsychosisastudyprotocolforahybridtype1trial AT susserezra ontrackchileforpeoplewithearlypsychosisastudyprotocolforahybridtype1trial AT dixonlisa ontrackchileforpeoplewithearlypsychosisastudyprotocolforahybridtype1trial AT alvaradoruben ontrackchileforpeoplewithearlypsychosisastudyprotocolforahybridtype1trial |